Announcements

October 30, 2023

Genetic Signatures (ASX:GSS) – Quarterly update and Appendix 4C

October 27, 2023

Genetics Signatures (ASX:GSS)- 2023 Notice of Annual General Meeting Proxy Form

September 19, 2023

Genetics Signatures (ASX:GSS) – Investor Presentation

View Announcement

September 4, 2023

Genetic Signatures (ASX:GSS) – FDA 510(k) Filing in Preparation for US Commercial Launch

View Announcement

September 4, 2023

Genetic Signatures (ASX:GSS) – FDA 510(k) Application for Gastrointestinal Parasite Detection Kit Submitted

View Announcement

August 31, 2023

Genetics Signatures (ASX:GSS) – Corporate Governance Statement

View Announcement

August 25, 2023

Influenza B Detection Expected to Impact on Quarter Sales

View Announcement

July 31, 2023

Genetic Signatures (ASX:GSS) – Quarterly update and Appendix 4C

View Announcement

June 16, 2023

Genetics Signatures (ASX:GSS) Appointment of Chief Financial Officer and Company Secretary

March 21, 2023

Genetics Signatures (ASX:GSS) Company Secretary, CFO Appointment and Resignation